A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Delta9-THC / Delta9-tetrahydrocannabinol

[Related PubMed/MEDLINE]
Total Number of Papers: 199
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Delta9-THC  (>> Co-occurring Abbreviation)
Long Form:   Delta9-tetrahydrocannabinol
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Cannabis Sativa Revisited-Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis. CBD
2020 Delta9-tetrahydrocannabinol and 2-AG decreases neurite outgrowth and differentially affects ERK1/2 and Akt signaling in hiPSC-derived cortical neurons. 2-AG, CB1R, CB2R, hiPSCs
2020 In-tube solid-phase microextraction with a dummy molecularly imprinted monolithic capillary coupled to ultra-performance liquid chromatography-tandem mass spectrometry to determine cannabinoids in plasma samples. CBD, CV, FTIR, MIP monolith, NIP monolith, RSD
2020 Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice. i.p, PPI
2020 Pharmacokinetics of Sativex in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders. CBD
2020 Review of NIOSH Cannabis-Related Health Hazard Evaluations and Research. HHE, LC-MS-MS, LOD, NIOSH, VOCs
2020 Synthetic route sourcing of illicit at home cannabidiol (CBD) isomerization to psychoactive cannabinoids using ion mobility-coupled-LC-MS/MS. CBD, LC-MS
2020 Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity. Delta9-THCA-A, RGZ, THCA-A
2019 A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Delta9-tetrahydrocannabinol: Delta9-Tetrahydrocannabiphorol. CBD, Delta9-THCP
10  2019 Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Delta9-THC at Human CB1 and CB2 Receptors. CB1, CB2
11  2019 Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Delta9-Tetrahydrocannabinol-Induced Cognitive Impairment. A2AR, CB1R, CBD
12  2019 Adolescent Delta9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-kappaB-Cyclooxygenase-2 Signaling to ImpairMemory in Adulthood. DN-DISC1
13  2019 Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Delta9-Tetrahydrocannabinol Exposure. NAc
14  2019 Analytical quality by design: Development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extracts. CBD, CMAs
15  2019 Association between increased retinal background noise and co-occurrent regular cannabis and alcohol use. ERG
16  2019 Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells. AC, BFC
17  2019 Cannabinoids Delta9-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-kappaB signaling. CBD, METH, TLRs, Toll-like 4
18  2019 Chemical and physical variations of cannabis smoke from a variety of cannabis samples in New Zealand. ---
19  2019 Dark Classics in Chemical Neuroscience: Delta9-Tetrahydrocannabinol. CB1
20  2019 Delta9-Tetrahydrocannabinol leads to endoplasmic reticulum stress and mitochondrial dysfunction in human BeWo trophoblasts. ER
21  2019 Delta9-Tetrahydrocannabinol upregulates fatty acid 2-hydroxylase (FA2H) via PPARalpha induction: A possible evidence for the cancellation of PPARbeta/delta-mediated inhibition of PPARalpha in MDA-MB-231 cells. FA2H, PPARs
22  2019 Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research. CBD
23  2019 Endocannabinoid System and Alcohol Abuse Disorders. AUD, CB, CB1R, CB2R, CNS, eCB, FASD
24  2019 Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment. CBD, CBD, TRPV1
25  2019 Increased sensitivity to Delta9-THC-induced rewarding effects after seven-week exposure to electronic and tobacco cigarettes in mice. CIG, CPP, E-cigs, NAc
26  2019 Pharmacology of Medical Cannabis. CBD
27  2019 Plant-Based Modulators of Endocannabinoid Signaling. ECSS
28  2019 Potency Analysis of Medical Marijuana Products from New York State. CBD, HPLC-PDA, NYS
29  2019 Potential occupational and respiratory hazards in a Minnesota cannabis cultivation and processing facility. Delta9-THCA, NIOSH, VOCs
30  2019 Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Delta9-Tetrahydrocannabinol and JWH-018. CB1R, IQD
31  2019 Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI. ---
32  2019 Step toward Roadside Sensing: Noninvasive Detection of a THC Metabolite from the Sweat Content of Fingerprints. UV-vis
33  2019 Tolerance and dependence to Delta9-tetrahydrocannabinol in rhesus monkeys: Activity assessments. ---
34  2019 Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice. CB1, GRK
35  2019 Topical review on monitoring tetrahydrocannabinol in breath. ---
36  2018 Anti-Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Delta9-Tetrahydrocannabinol/Sesame Oil on Adjuvant-Induced Arthritis in Rats. AIA, ESR, IL-1beta, IL-6, MTX, RA, SOD, TNF-alpha
37  2018 Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Delta9-THC. CB1Rs, HLMs, LC/MS, SCBs
38  2018 Bioactive products from singlet oxygen photooxygenation of cannabinoids. Delta8-THC, Delta9-THCA
39  2018 Cannabinoid disruption of learning mechanisms involved in reward processing. CUD
40  2018 Cannabinoid Ligands Targeting TRP Channels. AEA, NADA, TRP, TRPA, TRPM, TRPV
41  2018 Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans. CB1R, CBD, EEG, LFPs
42  2018 Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System. CBD, ECS, FDA
43  2018 Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer. CBD, COX-2, NCI
44  2018 Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2. AEA
45  2018 Delta9-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats. ---
46  2018 Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID. CBD
47  2018 Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids. 2-AG
48  2018 Drug-drug interactions as a result of co-administering Delta9-THC and CBD with other psychotropic agents. CBD, DDIs
49  2018 Effect of repeated juvenile exposure to Delta9‑tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats. ---
50  2018 Effects of Delta9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats. AST, BW
51  2018 Highway to hell or magic smoke? The dose-dependence of Delta9-THC in place conditioning paradigms. PC
52  2018 Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing. ---
53  2018 Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure. ---
54  2018 Review of the neurological benefits of phytocannabinoids. CBD, ECS
55  2018 Structural and Functional Interaction of Delta9-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1). CD, EC, NBD-AEA, WT
56  2018 Suspected Synthetic Cannabinomimetic Intoxication: Case Series and Review. ED, SC, UKCMC
57  2018 Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats. ACh, CBD
58  2018 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution. NPS, SCRAs
59  2018 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins. NPS, SCRAs
60  2018 The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Delta9-THC) in humans. ---
61  2018 The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study. CARE-E, CBD
62  2018 Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys. VE
63  2017 Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Delta9-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring. ICSS
64  2017 Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease. CBs, ECS, HD
65  2017 Cannabidiol in medical marijuana: Research vistas and potential opportunities. CBD, RDoC
66  2017 Cannabinoids assessment in plasma and urine by high performance liquid chromatography-tandem mass spectrometry after molecularly imprinted polymer microsolid-phase extraction. AIBN, CBD, CBN, Delta9-THC-OH, DVB, EGDMA, MIP, PP
67  2017 Cannabis sativa (Hemp) Seeds, Delta9-Tetrahydrocannabinol, and Potential Overdose. CBD
68  2017 Cannabis, cannabinoids, and health. SC
69  2017 CB1 and CB2 Receptor Pharmacology. CB1R, CB2R, GPCR
70  2017 CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Delta9-Tetrahydrocannabinol (Delta9-THC)-Induced Aversive Effects in Mice. CB1Rs, ICSS, VGLUT2, VTA
71  2017 Crystal structures of agonist-bound human cannabinoid receptor CB1. CB1
72  2017 Delta9-tetrahydrocannabinol (Delta9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. NOR, NR1, PPI
73  2017 Determination of Cannabinoid Vapor Pressures to Aid in Vapor Phase Detection of Intoxication. CBD, EOS, NBT, PLOT-cryo
74  2017 Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Delta9-Tetrahydrocannabivarin, and Cannabigerol in Mouse Peripheral Tissues. CBD, CBDV, CBG, Delta9-THCV
75  2017 Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition. CBD
76  2017 Effects of chronic Delta9-tetrahydrocannabinol treatment on Rho/Rho-kinase signalization pathway in mouse brain. ---
77  2017 Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? ECS
78  2017 Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites. SCBs
79  2017 Phytochemistry of Cannabis sativa L. CBC, CBD, CBG
80  2017 Qualitative and quantitative measurement of cannabinoids in cannabis using modified HPLC/DAD method. CBG, DAD, Delta8-THC, HPLC, OP, THCA
81  2017 Sex differences in the subjective effects of oral Delta9-THC in cannabis users. VAS
82  2017 Synthetic Pot: Not Your Grandfather's Marijuana. SCBs
83  2017 The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents. 2-AG, AMT, FAAH, MAGL
84  2017 The Impact of Delta9-THC on the Psychological Symptoms of Anorexia Nervosa: A Pilot Study. AN
85  2016 Acute and chronic effects of cannabidiol on Delta⁹-tetrahydrocannabinol (Delta⁹-THC)-induced disruption in stop signal task performance. CBD, RT, SSRT, SST
86  2016 Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review. CBD
87  2016 Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats. CB1
88  2016 Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence. ---
89  2016 Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration. CB1, TCA
90  2016 Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. CBD, CBDA, CBG, CBGA, THCA-A
91  2016 Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model. CBD
92  2016 Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis. PD, PGC-1alpha, PPARgamma
93  2016 Delta9-Tetrahydrocannabinol (Delta9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques. BDNF, miR, SIV, THC, VEH
94  2016 Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. CB, GPCR, SCs
95  2016 Driving under the effect of drugs: Hair analysis in order to evaluate recidivism. ---
96  2016 Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence. ---
97  2016 Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. CBD
98  2016 Stability of dronabinol capsules when stored frozen, refrigerated, or at room temperature. HPLC, UV
99  2015 Chronic administration of Delta9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques. days p.i, GI, HIV, miRNA, NOX4, SIV
100  2015 Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids. EAE, MS